Bone Density, LowNCT06375096
Bone Mineral Density in Children With Graves' Disease
An observational study of Bone Density, Low and Bone Mineral Density in Children With Graves' Disease, run by Assiut University.
Trial summary
to evaluate bone mineral density in children with graves' disease Read more about this study
- Who is it for?
- Ages 2 to 18 years
- Conditions the study is for
- Bone Density, Low, Bone Mineral Density in Children With Graves' Disease
- What is being tested?
- evaluate bone mineral density
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 25 Jun 2024to 25 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 18 years
- All sexes
- Child, Adult
Study population: children diagnosed with graves' disease, more than 2 years and less than 18 years
Who may be able to join
- age at enrollment ≥2 years to < 18 years
- both sexes
- the patients should be diagnosed with graves'
Who cannot join
- patients less than 2 years
- patients more than 18 years
- Controlled GD patients on antithyroid
- patients with other endocrine diseases
Trial locations and contacts
No sites are listed yet.
About this study
to evaluate bone mineral density in children with graves' disease
- Being tested
- evaluate bone mineral density
- Medical subject headings
- Bone Diseases, Metabolic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
evaluate bone mineral densityOther
observation effect of graves' in bone mineral density in children
What is being measured
The primary outcome is the main question the study is designed to answer.
bone mineral density
measure bone mineral density in children diagnosed with graves' disease, to evaluate the effect of the disease on it and the effect of antithyroid medication after that
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Apr 2024
- Study start25 Jun 2024 (estimated)
- Primary completion25 Jun 2025 (estimated)
- Study completion25 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bone Density, LowStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hadeer Youssef Mahmoud Nasr, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06375096
- Sponsor's protocol ID
- Graves' disease
- Status last verified
- Apr 2024
- First submitted
- 25 Mar 2024
- Last updated
- 19 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 19 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Bone Mineral Density in Children With Graves' Disease
- ClinicalTrials.gov ID
- NCT06375096
- Acronym / sponsor ID
- Graves' disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 25 Jun 2024 (estimated)
- Primary completion
- 25 Jun 2025 (estimated)
- Study completion
- 25 Jun 2025 (estimated)
- First posted
- 19 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
to evaluate bone mineral density in children with graves' disease
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 2 to 18 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- children diagnosed with graves' disease, more than 2 years and less than 18 years
Key inclusion criteria (3 listed)
- age at enrollment ≥2 years to < 18 years
- both sexes
- the patients should be diagnosed with graves'
Key exclusion criteria (4 listed)
- patients less than 2 years
- patients more than 18 years
- Controlled GD patients on antithyroid
- patients with other endocrine diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| evaluate bone mineral densityobservation effect of graves' in bone mineral density in children | Other | – |
Primary outcome
bone mineral density
Time frame: 1 month
measure bone mineral density in children diagnosed with graves' disease, to evaluate the effect of the disease on it and the effect of antithyroid medication after that
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Apr 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Bone Density, Low
Not yet recruitingPhase 2
Melatonin in Posterior Mandible Extraction Socket
Bone Loss
Active, not recruitingObservational study
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Cystic Fibrosis, Bone Loss
Active, not recruiting
AI-Supported Mobile High-Impact and Strengthening Exercise Program in Postmenopausal Women With Low Bone Density
Osteopenia
Active, not recruiting
L-PRF Block vs Composite Graft for Horizontal Ridge Augmentation
Alveolar Ridge Resorption After Extraction, Alveolar Bone Loss
RecruitingObservational study
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Bone Density, Low and Bone Mineral Density in Children With Graves' Disease, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hadeer Youssef Mahmoud (01110548137, hadeeryoussef754@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
bone mineral density (time frame: 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2024.